Supplemental Figure 1 from the MET Inhibitor AZD6094 (savolitinib, HMPL-504) Induces Regression in Papillary Renal Cell Carcinoma Patient–Derived Xenograft ModelsAlwin G. Schuller,Evan R. Barry,Rhys D.O. Jones, Ryan E. Henry,Melanie M. Frigault,Garry Beran, David Linsenmayer,Maureen Hattersley,Aaron Smith,Joanne Wilson,Stefano Cairo,Olivier Déas,Delphine Nicolle,Ammar Adam,Michael Zinda,Corinne Reimer, Stephen E. Fawell,Edwin A. Clark, Celina M. D'Cruzcrossref（2023）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
